Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Abstract 2982: Monomerization of ALK fusion proteins as a therapeutic strategy in ALK rearranged cancers

Noriko Hirai, Takaaki Sasaki, Yoshinobu Ohsaki

Cancer Res (2019) 79 (13_Supplement): 2982.

https://doi.org/10.1158/1538-7445.AM2019-2982

Published: 01 July 2019

View article titled, Abstract 2982: Monomerization of ALK fusion proteins as a therapeutic strategy in ALK rearranged cancers

Journal Articles

Abstract 648: Digital PCR in genetic diagnosis of NUT midline carcinoma

Shunsuke Okumura, Shin-ichi Chiba, Masatoshi Sado, Nana Takahashi, Takaaki Sasaki, Masahiro Kitada, Yoshinobu Ohsaki

Cancer Res (2018) 78 (13_Supplement): 648.

https://doi.org/10.1158/1538-7445.AM2018-648

Published: 01 July 2018

View article titled, Abstract 648: Digital PCR in genetic diagnosis of NUT midline carcinoma

Journal Articles

Abstract 749: Novel ALK specific mRNA in situ hybridization assay for non-small cell lung carcinoma

Noriko Hirai, Takaaki Sasaki, Yoshinobu Ohsaki

Cancer Res (2017) 77 (13_Supplement): 749.

https://doi.org/10.1158/1538-7445.AM2017-749

Published: 01 July 2017

View article titled, Abstract 749: Novel ALK specific mRNA in situ hybridization assay for non-small cell lung carcinoma

Journal Articles

Abstract 3148: Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer

Ryohei Yoshida, Takaaki Sasaki, Shunsuke Okumura, Yoshinobu Ohsaki

Cancer Res (2017) 77 (13_Supplement): 3148.

https://doi.org/10.1158/1538-7445.AM2017-3148

Published: 01 July 2017

View article titled, Abstract 3148: Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer

Journal Articles

Abstract 2267: Efficacy of pemetrexed-based chemotherapy in patients with NSCLC harboring KRAS mutations

Shunsuke Okumura, Takaaki Sasaki, Shin-ichi Chiba, Masatoshi Sado, Naoyuki Miyokawa, Hiroshi Funakoshi, Yoshinobu Ohsaki

Cancer Res (2016) 76 (14_Supplement): 2267.

https://doi.org/10.1158/1538-7445.AM2016-2267

Published: 15 July 2016

View article titled, Abstract 2267: Efficacy of pemetrexed-based chemotherapy in patients with NSCLC harboring KRAS mutations

Journal Articles

Abstract 3501: EGFR tyrosine kinase inhibitors combined with cytotoxic drugs for treatment of NSCLC with EGFR gene mutations: Efficacy and mechanisms

Ryohei Yoshida, Synsuke Okumura, Takaaki Sasaki, Yoshinobu Ohsaki

Cancer Res (2015) 75 (15_Supplement): 3501.

https://doi.org/10.1158/1538-7445.AM2015-3501

Published: 01 August 2015

View article titled, Abstract 3501: EGFR tyrosine kinase inhibitors combined with cytotoxic drugs for treatment of NSCLC with EGFR gene mutations: Efficacy and mechanisms

Journal Articles

Abstract 1770: A role of nicotinamide phosphoribosyltransferase in growth of KRAS mutant non-small cell lung cancer

Shunsuke Okumura, Takaaki Sasaki, Yoshinobu Ohsaki

Cancer Res (2015) 75 (15_Supplement): 1770.

https://doi.org/10.1158/1538-7445.AM2015-1770

Published: 01 August 2015

View article titled, Abstract 1770: A role of nicotinamide phosphoribosyltransferase in growth of KRAS mutant non-small cell lung cancer

Journal Articles

Abstract 4656: The novel mRNA in situ hybridization method for the detection of ALK, RET, ROS1 and NTRK1 mRNA in non-small cell lung cancer

Noriko Hirai, Takaaki Sasaki, Yoshinori Minami, Yoshinobu Ohsaki

Cancer Res (2014) 74 (19_Supplement): 4656.

https://doi.org/10.1158/1538-7445.AM2014-4656

Published: 01 October 2014

View article titled, Abstract 4656: The novel mRNA in situ hybridization method for the detection of ALK, RET, ROS1 and NTRK1 mRNA in non-small cell lung cancer

Journal Articles

Abstract 3720: Intrinsic and acquired resistance mechanisms of alectinib in ALK rearranged cells

Yukiko Hibino, Sasaki Takaaki, Yoshinori Minami, Pasi A. Janne, Yoshinobu Ohsaki

Cancer Res (2014) 74 (19_Supplement): 3720.

https://doi.org/10.1158/1538-7445.AM2014-3720

Published: 01 October 2014

View article titled, Abstract 3720: Intrinsic and acquired resistance mechanisms of alectinib in ALK rearranged cells

Journal Articles

Abstract 371: PGI₂ analog enhances endothelial-pericyte interactions and suppresses lung metastasis.

Yoshinori Minami, Takaaki Sasaki, Satoshi Endo, Kiyoko Shibukawa, Yoshinobu Ohsaki

Cancer Res (2013) 73 (8_Supplement): 371.

https://doi.org/10.1158/1538-7445.AM2013-371

Published: 15 April 2013

View article titled, Abstract 371: PGI2 analog enhances endothelial-pericyte interactions and suppresses lung metastasis.

Journal Articles

Abstract 4209: Genotypic agreement between histological specimen and preoperative cytology in small lung adenocarcinoma.

Noriko Hirai, Sasaki Takaaki, Yoshinori Minami, Masahiro Kitada, Naoyuki Miyokawa, Yoshinobu Ohsaki

Cancer Res (2013) 73 (8_Supplement): 4209.

https://doi.org/10.1158/1538-7445.AM2013-4209

Published: 15 April 2013

View article titled, Abstract 4209: Genotypic agreement between histological specimen and preoperative cytology in small lung adenocarcinoma.

Journal Articles

Abstract 4379: Activating the prostaglandin I₂-IP signaling suppresses metastasis in lung cancer

Yoshinori Minami, Satoshi Endo, Shunsuke Okumura, Kiyoko Shibukawa, Takaaki Sasaki, Yoshinobu Ohsaki

Cancer Res (2012) 72 (8_Supplement): 4379.

https://doi.org/10.1158/1538-7445.AM2012-4379

Published: 15 April 2012

View article titled, Abstract 4379: Activating the prostaglandin I2-IP signaling suppresses metastasis in lung cancer

Journal Articles

Abstract 1576: Prostaglandin I₂ signaling regulates micro-metastasis in lung cancer

Yoshinori Minami, Shunsuke Okumura, Takaaki Sasaki, Junichi Kawabe, Satoshi Endo, Kazuhiro Satoh, Masahiro Kitada, Yuka Fujita, Naoyuki Hasebe, Yoshinobu Ohsaki

Cancer Res (2011) 71 (8_Supplement): 1576.

https://doi.org/10.1158/1538-7445.AM2011-1576

Published: 15 April 2011

View article titled, Abstract 1576: Prostaglandin I2 signaling regulates micro-metastasis in lung cancer

Journal Articles

Abstract 964: Nicotinamide phosphoribosyltransferase (Nampt) regulates growth of non-small cell lung cancer cells with c-Met overexpression

Shunsuke Okumura, Yoshinori Minami, Satoshi Endoh, Takaaki Sasaki, Kazuhiro Satoh, Masahiro Kitada, Yoshinobu Ohsaki

Cancer Res (2011) 71 (8_Supplement): 964.

https://doi.org/10.1158/1538-7445.AM2011-964

Published: 15 April 2011

View article titled, Abstract 964: Nicotinamide phosphoribosyltransferase (Nampt) regulates growth of non-small cell lung cancer cells with c-Met overexpression

Journal Articles

Impaired functional endothelial progenitor cells inhibited growth of tumor - Prostacyclin signaling as a target for cancer therapy -

Takaaki Sasaki, Shunsuke Okumura, Kiyoko Shibukawa, Shinobu Osanai, Jun-ichi Kawabe, Yoshinobu Ohsaki

Cancer Res (2008) 68 (9_Supplement): 1099.

Published: 01 May 2008

View article titled, Impaired functional endothelial progenitor cells inhibited growth of tumor - Prostacyclin signaling as a target for cancer therapy -

Journal Articles

Antiangiogenic therapy of human small-cell lung cancer with vascular endothelial growth factor receptor tyrosine kinase inhibitor, ZD6474

Takaaki Sasaki, Sachie Tanno, Kiyoko Shibukawa, Shinobu Osanai, Kenjiro Kikuchi, Yoshinobu Ohsaki

Cancer Res (2007) 67 (9_Supplement): 3999.

Published: 01 May 2007

View article titled, Antiangiogenic therapy of human small-cell lung cancer with vascular endothelial growth factor receptor tyrosine kinase inhibitor, ZD6474

Journal Articles

Human lung adenocarcinoma express various levels of functional COX-2 protein, and the expression was increased by pro-inflammatory cytokines

Kyoko Nakanishi, Takaaki Sasaki, Kiyoko Shibukawa, Sachie Tanno, Kenjiro Kikuchi, Yoshinobu Ohsaki

Cancer Res (2006) 66 (8_Supplement): 817–818.

Published: 15 April 2006

View article titled, Human lung adenocarcinoma express various levels of functional COX-2 protein, and the expression was increased by pro-inflammatory cytokines

Journal Articles

Loss of heterozygosity in early bronchogenic carcinoma and precancerous lesions, which were found by auto-fluorescence bronchoscopy

Kiyoko Shibukawa, Yoshinobu Ohsaki, Yoshihiko Tokusashi, Takaaki Sasaki, Kyoko Nakanishi, Hiroaki Nakata, Hikaru Kuroda, Shoko Nakao, Saori Takahashi, Masaaki Takahashi, Toru Takahashi, Shinobu Osanai, Kenjiro Kikuchi, Kaneyoshi Takeyama, Susumu Nakajima, Naoyuki Miyokawa

Cancer Res (2006) 66 (8_Supplement): 1068–1069.

Published: 15 April 2006

View article titled, Loss of heterozygosity in early bronchogenic carcinoma and precancerous lesions, which were found by auto-fluorescence bronchoscopy

Journal Articles

Human Small Cell Lung Cancer Cell Lines Express Functional Atrial Natriuretic Peptide Receptors

Yoshinobu Ohsaki, Han-Kwang Yang, Phuong Tram Le, Robert T. Jensen, Bruce E. Johnson

Cancer Res (1993) 53 (13): 3165–3171.

Published: 01 July 1993

View article titled, Human Small Cell Lung Cancer Cell Lines Express Functional Atrial Natriuretic Peptide Receptors

Journal Articles

Antitumor Activity of Magainin Analogues against Human Lung Cancer Cell Lines

Yoshinobu Ohsaki, Adi F. Gazdar, Hao-Chia Chen, Bruce E. Johnson

Cancer Res (1992) 52 (13): 3534–3538.

Published: 01 July 1992

View article titled, Antitumor Activity of Magainin Analogues against Human Lung Cancer Cell Lines

NARROW

Abstract 2982: Monomerization of ALK fusion proteins as a therapeutic strategy in ALK rearranged cancers

Abstract 648: Digital PCR in genetic diagnosis of NUT midline carcinoma

Abstract 749: Novel ALK specific mRNA in situ hybridization assay for non-small cell lung carcinoma

Abstract 3148: Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer

Abstract 2267: Efficacy of pemetrexed-based chemotherapy in patients with NSCLC harboring KRAS mutations

Abstract 3501: EGFR tyrosine kinase inhibitors combined with cytotoxic drugs for treatment of NSCLC with EGFR gene mutations: Efficacy and mechanisms

Abstract 1770: A role of nicotinamide phosphoribosyltransferase in growth of KRAS mutant non-small cell lung cancer

Abstract 4656: The novel mRNA in situ hybridization method for the detection of ALK, RET, ROS1 and NTRK1 mRNA in non-small cell lung cancer

Abstract 3720: Intrinsic and acquired resistance mechanisms of alectinib in ALK rearranged cells

Abstract 371: PGI₂ analog enhances endothelial-pericyte interactions and suppresses lung metastasis.

Abstract 4209: Genotypic agreement between histological specimen and preoperative cytology in small lung adenocarcinoma.

Abstract 4379: Activating the prostaglandin I₂-IP signaling suppresses metastasis in lung cancer

Abstract 1576: Prostaglandin I₂ signaling regulates micro-metastasis in lung cancer

Abstract 964: Nicotinamide phosphoribosyltransferase (Nampt) regulates growth of non-small cell lung cancer cells with c-Met overexpression

Impaired functional endothelial progenitor cells inhibited growth of tumor - Prostacyclin signaling as a target for cancer therapy -

Antiangiogenic therapy of human small-cell lung cancer with vascular endothelial growth factor receptor tyrosine kinase inhibitor, ZD6474

Human lung adenocarcinoma express various levels of functional COX-2 protein, and the expression was increased by pro-inflammatory cytokines

Loss of heterozygosity in early bronchogenic carcinoma and precancerous lesions, which were found by auto-fluorescence bronchoscopy

Human Small Cell Lung Cancer Cell Lines Express Functional Atrial Natriuretic Peptide Receptors

Antitumor Activity of Magainin Analogues against Human Lung Cancer Cell Lines

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only